In obesity-related high plasma leptin conditions, inflammation occurs when signal transduction pathways are activated, such as activation of NFκβ, by the binding of leptin to its receptor (Ob-R), and subsequent release of the inflammation factors, for instance tumour necrosis factor alpha (TNFα) [11]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.